Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Sedation (preoperative, ICU settings)
* Status epilepticus and seizure management
## Adult Dosing
* **Anxiety:** 1-4 mg orally every 6-8 hours. Maximum: 10 mg/day.
* **Insomnia:** 2-4 mg orally at bedtime. Generally for short-term use only.
* **Preoperative Sedation:** 2-4 mg intramuscularly (IM) or intravenously (IV) 2 hours before surgery.
* **Status Epilepticus:** 4 mg IV initially. If seizures persist or recur within 10-15 minutes, a second dose of 4 mg IV may be administered. Maximum: 8 mg.
Dosing for specific indications like ICU sedation may vary based on local protocols and patient response.
## Pediatric Dosing
* **Seizure Management (Status Epilepticus):** 0.1 mg/kg IV, IM, or rectally, not to exceed 4 mg per dose. Doses can be repeated every 5-10 minutes if needed, up to a maximum of 0.1 mg/kg or 4 mg total.
* Data for other indications in the pediatric population is limited.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution, may require dose reduction.
* **Renal Impairment:** Dose adjustment is generally not required unless severe impairment.
* **Elderly:** Start with lower doses (e.g., 1-2 mg/day divided) and titrate cautiously due to increased sensitivity and risk of sedation, confusion, and falls.
## Contraindications
* Hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe liver dysfunction.
* Sleep apnea.
## Adverse Effects
Common adverse effects include drowsiness, dizziness, weakness, unsteadiness, and lethargy. Less common effects include confusion, depression, amnesia, paradoxical excitation, and hypotension.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline/Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* Monitor for excessive sedation, respiratory rate, blood pressure, and risk of falls, especially in the elderly.
* Assess for efficacy in treating anxiety, insomnia, or seizures.
* Monitor for signs of tolerance and dependence with prolonged use.
## Clinical Pearls
* Lorazepam has a relatively short half-life compared to other benzodiazepines, which can be advantageous for certain indications but may lead to more frequent dosing.
* Intramuscular administration is reliable and absorbed well.
* Withdrawal symptoms can occur with abrupt discontinuation after prolonged use; taper gradually.
* Use in pregnancy should be avoided, particularly in the first trimester, due to potential risks to the fetus.
***
*This information is intended for healthcare professionals. It is essential to consult the most current prescribing information, local protocols, and individual patient factors before initiating or modifying therapy.*
